Combining 2 VEGF-Blocking Targeted Therapies Significantly Boosted Survival in Kidney Cancer Study - Buffalo Healthy Living Magazine
Source: buffalohealthyliving.com
At a glance
Clinical trial assessing bevacizumab–pazopanib combination focused on patients with untreated metastatic disease Landmark study extended both progression-free and overall survival Regimen found to be safe and effective, especially in favorable-risk …